806-P: Correlation of Derived Time in Range (dTIR) and Time in Range (TIR) in People with Type 2 Diabetes (T2D) Treated with IDegLira (IDL) , Degludec, or Liraglutide: A Post Hoc A... von PHILIS-TSIMIKAS, ATHENA, DCRUZ, JOHN M., SIVARATHINASAMI, RAMSATHISH, DE BLOCK, CHRISTOPHE

Volltext

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes von Philis-Tsimikas, Athena, Aroda, Vanita R., De Block, Christophe, Billings, Liana K., Liebl, Andreas, Sivarathinasami, Ramsathish, D’Cruz, John M., Lingvay, Ildiko

Volltext

606-P: Higher Derived Time-in-Range with IDegLira vs. Insulin Glargine U100 in Patients with T2D von PHILIS-TSIMIKAS, ATHENA, ARODA, VANITA R., BLOCK, CHRISTOPHE DE, BILLINGS, LIANA K., HACHMANN-NIELSEN, ELISE, LIEBL, ANDREAS, SIVARATHINASAMI, RAMSATHISH, D'CRUZ, JOHN M., LINGVAY, ILDIKO

Volltext

Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial von Lane, Wendy, Favaro, Elena, Jódar, Esteban, Kelkar, Pranav, Oviedo, Alejandra, Sivarathinasami, Ramsathish, Senior, Peter A., Sesti, Giorgio, Franek, Edward

Volltext

Survey of the Frontline Treatment and Management of Chronic Myeloid Leukemia (CML) in a Real-Word Setting: The 3rd Annual Update of the Worldwide Observational Registry Collecting... von Pasquini, Ricardo, Cortes, Jorge E., Kantarjian, Hagop M., Joske, David, Meillon, Luis A, Zernovak, Oleg, Sivarathinasami, Ramsathish, Collins, LaTonya, Hughes, Timothy P., Kim, Dong-Wook

Volltext

First-Line Treatment and Management of Chronic Myeloid Leukemia (CML) in Clinical Practice: Update of > 1800 Patients (Pts) in the WORLD CML Registry von Cortes, Jorge E., Pasquini, Ricardo, Kantarjian, Hagop M., Joske, David, Meillon, Luis A, Shen, Zhixiang, Piccolo, Carmen, Zernovak, Oleg, Sivarathinasami, Ramsathish, Eng, Dawn F., Kim, Dong-Wook, Hughes, Timothy P.

Volltext